| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA96421
Max Phase: Preclinical
Molecular Formula: C19H23N3O
Molecular Weight: 309.41
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: OC1(Cc2ccccc2)CCN(CCC#Cc2c[nH]cn2)CC1
Standard InChI: InChI=1S/C19H23N3O/c23-19(14-17-6-2-1-3-7-17)9-12-22(13-10-19)11-5-4-8-18-15-20-16-21-18/h1-3,6-7,15-16,23H,5,9-14H2,(H,20,21)
Standard InChI Key: RLCZAACDUIBIAM-UHFFFAOYSA-N
Associated Targets(non-human)
Grin3a Glutamate [NMDA] receptor subunit 3A (29 Activities)
Grin1 Glutamate NMDA receptor; Grin1/Grin2b (1028 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Grin2c Glutamate [NMDA] receptor subunit epsilon 3 (367 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Rattus norvegicus (775804 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 309.41 | Molecular Weight (Monoisotopic): 309.1841 | AlogP: 2.22 | #Rotatable Bonds: 4 |
| Polar Surface Area: 52.15 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.53 | CX Basic pKa: 8.31 | CX LogP: 2.20 | CX LogD: 1.24 |
| Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.85 | Np Likeness Score: -0.18 |
References
| 1. Wright JL, Gregory TF, Boxer PA, Meltzer LT, Serpa KA, Wise LD.. (1999) Discovery of subtype-selective NMDA receptor ligands: 4-benzyl-1-piperidinylalkynylpyrroles, pyrazoles and imidazoles as NR1A/2B antagonists., 9 (19): [PMID:10522697] [10.1016/s0960-894x(99)00482-5] |
Source
Source(1):